Login
$BNGO
$1.22 +$0.06 (5.17%) Close

$BNGO 4/A SEC Filings

Filed On Filing
12 Sep 2025 Form 4/A: Oldakowski Mark, Chief Operating Officer

Gave up 59 shares to cover exercise price or tax ($240)

18 Jul 2022 Form 4/A: Twomey Christopher J, Director

Granted 44,470 Stock Option (Right to Buy)

18 Jul 2022 Form 4/A: Luderer Albert, Director

Granted 44,470 Stock Option (Right to Buy)

18 Jul 2022 Form 4/A: Linney Yvonne, Director

Granted 44,470 Stock Option (Right to Buy)

18 Jul 2022 Form 4/A: Vuori Kristiina Md, Director

Granted 44,470 Stock Option (Right to Buy)

18 Jul 2022 Form 4/A: Mamuszka Hannah, Director

Granted 44,470 Stock Option (Right to Buy)

03 Sep 2020 Form 4/A: Chaubey Alka, Chief Medical Officer

Granted 300,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support